SEC 13F Intelligence

Norinchukin Bank, The / LLY

Norinchukin Bank, The’s Eli Lilly & Co Position

Does Norinchukin Bank, The own Eli Lilly & Co (LLY)? Yes — 47.1K shares worth $43M (+0.51% of its 13F portfolio) as of Q1 2026, down from 47.2K shares the prior filed quarter.

Position Value
$43M
Q1 2026
Shares
47.1K
% of Portfolio
+0.51%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $26MQ4 ’18Q1 ’19: $27MQ2 ’19: $16MQ3 ’19: $17MQ4 ’19: $18MQ4 ’19Q1 ’20: $10MQ2 ’20: $12MQ3 ’20: $10MQ4 ’20: $11MQ4 ’20Q1 ’21: $12MQ2 ’21: $15MQ3 ’21: $16MQ4 ’21: $19MQ4 ’21Q1 ’22: $21MQ2 ’22: $15MQ3 ’22: $17MQ4 ’22: $16MQ4 ’22Q1 ’23: $16MQ2 ’23: $30MQ3 ’23: $17MQ4 ’23: $16MQ4 ’23Q1 ’24: $22MQ2 ’24: $25MQ3 ’24: $28MQ4 ’24: $26MQ4 ’24Q1 ’25: $32MQ2 ’25: $33MQ3 ’25: $34MQ4 ’25: $51MQ4 ’25Q1 ’26: $43Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202647.1K$43M+0.51%
Q4 202547.2K$51M+0.59%
Q3 202544.4K$34M+0.45%
Q2 202542.8K$33M+0.50%
Q1 202538.9K$32M+0.59%
Q4 202434.0K$26M+0.56%
Q3 202431.8K$28M+0.66%
Q2 202427.9K$25M+0.72%
Q1 202427.6K$22M+0.64%
Q4 202328.0K$16M+0.38%
Q3 202330.8K$17M+0.39%
Q2 202365.0K$30M+0.51%
Q1 202345.5K$16M+0.31%
Q4 202243.9K$16M+0.35%
Q3 202251.1K$17M+0.34%
Q2 202247.1K$15M+0.30%
Q1 202272.4K$21M+0.28%
Q4 202167.0K$19M+0.23%
Q3 202167.4K$16M+0.22%
Q2 202165.9K$15M+0.22%
Q1 202166.2K$12M+0.17%
Q4 202065.0K$11M+0.16%
Q3 202067.1K$10M+0.16%
Q2 202070.7K$12M+0.20%
Q1 202071.7K$10M+0.19%
Q4 2019137.4K$18M+0.24%
Q3 2019148.4K$17M+0.23%
Q2 2019147.6K$16M+0.25%
Q1 2019208.5K$27M+0.34%
Q4 2018221.3K$26M+0.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norinchukin Bank, The’s full portfolio or all institutional holders of LLY.